Automated protein-ligand crystallography for structure-based drug design

被引:68
作者
Mooij, Wijnand T. M.
Hartshorn, Michael J.
Tickle, Ian J.
Sharff, Andrew J.
Verdonk, Marcel L.
Jhoti, Harren
机构
[1] Astex Therapeutics Ltd., Cambridge CB4 0QA
关键词
Drug design; Electron density fitting; Fragment-based drug discovery; Ligand fitting; Protein-ligand complexes; X-ray diffraction;
D O I
10.1002/cmdc.200600074
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
An approach to automate protein-ligand crystallography is presented, with the aim of increasing the number of structures available to structure-based drug design. The methods we propose deal with the automatic interpretation of diffraction data for targets with known protein structures, and provide easy access to the results. Central to the system is a novel procedure that fully automates the placement of ligands into electron density maps. Automation provides on objective way to structure solution, whereas manual placement con be rather subjective, especially for data of low to medium resolution. Ligands are placed by docking into electron density, whilst taking care of protein-ligand interactions. The ligand fitting procedure has been validated on both public domain and in-house examples. Some of the latter deal with cocktails of low-molecular weight compounds, as used in fragment-based drug discovery by crystallography. For such library-screening experiments we show that the method can automatically identify which of the compounds from a cocktail is bound.
引用
收藏
页码:827 / 838
页数:12
相关论文
共 46 条
[1]   PHENIX:: building new software for automated crystallographic structure determination [J].
Adams, PD ;
Grosse-Kunstleve, RW ;
Hung, LW ;
Ioerger, TR ;
McCoy, AJ ;
Moriarty, NW ;
Read, RJ ;
Sacchettini, JC ;
Sauter, NK ;
Terwilliger, TC .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 :1948-1954
[2]  
[Anonymous], 2002, SPART 02
[3]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[4]  
Baxter CA, 1998, PROTEINS, V33, P367, DOI 10.1002/(SICI)1097-0134(19981115)33:3<367::AID-PROT6>3.0.CO
[5]  
2-W
[6]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[7]   Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT [J].
Blanc, E ;
Roversi, P ;
Vonrhein, C ;
Flensburg, C ;
Lea, SM ;
Bricogne, G .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 :2210-2221
[8]   Bayesian statistical viewpoint on structure determination: Basic concepts and examples [J].
Bricogne, G .
MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 :361-423
[9]   Automated crystallographic system for high-throughput protein structure determination [J].
Brunzelle, JS ;
Shafaee, P ;
Yang, XJ ;
Weigand, S ;
Ren, Z ;
Anderson, WF .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2003, 59 :1138-1144
[10]   THE DEVELOPMENT AND USE OF QUANTUM-MECHANICAL MOLECULAR-MODELS .76. AM1 - A NEW GENERAL-PURPOSE QUANTUM-MECHANICAL MOLECULAR-MODEL [J].
DEWAR, MJS ;
ZOEBISCH, EG ;
HEALY, EF ;
STEWART, JJP .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1985, 107 (13) :3902-3909